BIOPHYTIS S.A.
Last · Paris€0.0461-0.0026 (-5.34%)stale · yahoo · 39h ago
Market cap€16.1M350.1M sh
P/E · TTM-0.1fwd -0.0 · eps -0.36 · loss
Beta1.71vs S&P 500
Div yield0.00%annual · TTM
52w range
€0.0042€0.16
Volume1.9Msession
Loading chart…
Documents
FormReporting forFiledFlags
8-KBIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
2026-10-122026-10-1208-KBIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
2026-09-112026-09-1108-KBiophytis to evaluate BIO101’s potential to limit weight regain in its OBA clinical study in obesity
2026-09-092026-09-090